共 50 条
- [21] AT13148, an orally bioavailable AKT kinase inhibitor with potent anti-tumor activity in both in vitro and in vivo models exhibiting AKT pathway deregulationMOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3512S - 3512SLyons, John F.Grimshaw, Kyla M.Woodhead, Steven J.Feltell, Ruth E.Reule, MatthiasSmyth, TomkoSeavers, Lisa C.Harada, IsobelleHiggins, JacquelineSmith, Donna M.Fazal, LynseyWorkman, PaulCollins, IanGarrett, Michelle D.Thompson, Neil T.
- [22] Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 ActivityACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 483 - 487Xue, Chu-BiaoChen, LihuaCao, GanfengZhang, KeWang, AnlaiMeloni, DavidGlenn, JosephAnand, RajanXia, MichaelKong, LingHuang, TaishengFeng, HaoZheng, ChangshengLi, MeiGalya, LaurineZhou, JiachengShin, NiuBaribaud, FredricSolomon, KimScherle, PeggyZhao, BitaoDiamond, SharonEmm, TomKeller, DouglasContel, NancyYeleswaram, SwamyVaddi, KrisHollis, GregoryNewton, RobertFriedman, StevenMetcalf, Brian
- [23] Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway ScreenJOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (04) : 1717 - 1735Mallinger, AurelieCrumpler, SimonPichowicz, MarkWaalboer, DennisStubbs, MarkAdeniji-Popoola, OlajumokeWood, BozenaSmith, ElizabethThai, ChingHenley, Alan T.Georgi, KatrinCourt, WilliamHobbs, SteveBox, GaryOrtiz-Ruiz, Maria-JesusValenti, MelanieBrandon, Alexis De HavenTePoele, RobertLeuthner, BirgittaWorkman, PaulAherne, WynnePoeschke, OliverDale, TrevorWienke, DirkEsdar, ChristinaRohdich, FelixRaynaud, FlorenceClarke, Paul A.Eccles, Suzanne A.Stieber, FrankSchiemann, KaiBlagg, Julian
- [24] Discovery of highly potent HDAC8 PROTACs with anti-tumor activityBIOORGANIC CHEMISTRY, 2023, 136Zhao, ChunlongChen, DengSuo, FengzhiSetroikromo, RitaQuax, Wim J.Dekker, Frank J.
- [25] A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cellsONCOTARGET, 2015, 6 (28) : 24895 - 24903Fujiyuki, TomokoYoneda, MisakoAmagai, YosukeObayashi, KunieIkeda, FusakoShoji, KoichiroMurakami, YoshinoriSato, HirokiKai, Chieko
- [26] CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunityPLOS ONE, 2023, 18 (06):Sullivan, Kathleen M. C.Vilalta, MartaErtl, Linda S.Wang, YuDunlap, CarolynEbsworth, KarenZhao, Bin N.Li, ShijieZeng, YibinMiao, ZhenhuaFan, PingchenMali, VenkatLange, ChristopherMcMurtrie, DarrenYang, JuLui, RebeccaScamp, RyanChhina, VickyKumamoto, AliceYau, SimonDang, TonEasterday, AshtonLiu, ShirleyMiao, ShichangCharo, IsraelSchall, Thomas J.Zhang, Penglie
- [27] Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerCANCERS, 2020, 12 (09) : 1 - 17Wen, WeiHan, Ernest S.Dellinger, Thanh H.Lu, Leander X.Wu, JunJove, RichardYim, John H.
- [28] A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activityCANCER LETTERS, 2020, 493 : 91 - 101Tao, HuiminCheng, LuLiu, LihuaWang, HongJiang, ZhijieQiang, XuXing, LijunXu, YifengCai, XinyingYao, JingWang, MinQiu, Zheng
- [29] BROAD ANTI-TUMOR ACTIVITY OF A POTENT AND SELECTIVE SMALL MOLECULE ANTAGONIST OF PD-L1 ABSK043 IN COMBINATION WITH OTHER AGENTS IN PRECLINICAL MODELSJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A943 - A943Ying, HaiyanZhang, YongxianYang, FeiXin, WenqunWang, JieZhang, JieChen, Zhui
- [30] NVP-BEP800: an orally bioavailable small molecule Hsp90 inhibitor with potent in vivo antitumor activityCANCER RESEARCH, 2009, 69Jensen, MichaelSchoepfer, JosephMassey, AndrewBrough, PaulBrueggen, JosefSchweitzer, AlainPfaar, UlrikeQuadt, CorneiiaDrysdale, MartinChene, PatrickGarcia-Echeverria, Carlos